CiQUS researchers develop a broad-spectrum inhibitor to combat infections caused by P. aeruginosa, the paradigm of bacterial resistance to antibiotics.
The compounds developed by Prof. González Bell...
Today researchers at the CRG are amongst some of the world’s leading scientists in receiving funding from the European Research Council’s Advanced Grants Competition. The grant is dedicated lon...
Researchers from Institute of Molecular Biology of Barcelona (IBMB-CSIC) –based in the Barcelona Science Park– and the Institute for Natural Science and Technology at the University of Osaka, ha...
An alternative to the use of antibiotics created by the group of Dr. Rafael Mañez, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital (HUB), has been sel...
Scientists from the Institute for Research in Biomedicine (IRB Barcelona), at the Barcelona Science Park, and the Spanish National Research Council (CSIC) have combined cryomicroscopy and crystallogra...
A study led by ISGlobal, an institution supported by the "la Caixa" Foundation, detects the presence of Haemophilus ducreyi, an ulcer-causing bacterium, on intact skin of asymptomatic children. It was...